4.5 Article

Biocompatible Polycationic Silver Nanocluster-Impregnated PLGA Nanocomposites with Potent Antimicrobial Activity

期刊

CHEMNANOMAT
卷 8, 期 11, 页码 -

出版社

WILEY-V C H VERLAG GMBH
DOI: 10.1002/cnma.202200349

关键词

Antimicrobial Activity; Cationic Silver Nanoclusters; Controlled Release; PLGA Nanocomposites

资金

  1. NHMRC [GNT1194466]
  2. Council of Scientific & Industrial Research (CSIR), New Delhi [HCP-0030]
  3. CSIR-Institute of Minerals & Materials Technology (IMMT), Bhubaneswar [OLP-110]
  4. University of South Australia
  5. State Government
  6. Federal Government

向作者/读者索取更多资源

Poly(lactic-co-glycolic) acid (PLGA) was explored as an effective carrier for polycationic silver nanoclusters (pAgNCs), leading to the development of biocompatible pAgNCs@PLGA nanocomposites with potent antimicrobial activity and high biocompatibility, holding promise for their application in medical practice.
Ultrasmall cationic silver nanoparticles (AgNPs) have recently emerged as highly potent antimicrobial agents for the treatment of multidrug-resistant bacteria and their biofilms. However, the clinical application of these cationic AgNPs is hampered by their poor stability and high reactivity in solution, leading to uncontrolled release of toxic silver ions. An ideal platform featuring broad-spectrum antibacterial activity and high biocompatibility that prevents overexposure to silver ions, is therefore highly desirable. Herein, we explored a biocompatible and biodegradable polymer, poly(lactic-co-glycolic) acid (PLGA) as an effective carrier for the recently discovered polycationic silver nanoclusters (pAgNCs). These pAgNCs impregnated PLGA nanocomposites (pAgNCs@PLGA) were developed by water-in-oil-in-water (W-1/O/W-2) emulsion method and characterized by various analytical techniques. Our experimental results reveal that pAgNCs@PLGA had spherical morphology with an average diameter of similar to 188 nm and consists of multiple ultrasmall (similar to 2 nm) pAgNCs at the polymeric core. The minimum inhibitory concentration of pAgNCs for Staphylococcus aureus and Pseudomonas aeruginosa were found to be 6.9 mu g/mL. After impregnation within PLGA, the antimicrobial efficacy of our pAgNCs against Staphylococcus aureus and Pseudomonas aeruginosa remained consistent, while the nanocomposites were biocompatible at the minimum inhibitory concentration (MIC) against both bacteria. The pAgNCs@PLGA nanocomposite developed in this work may present a path forward to bring these highly potent pAgNCs into medical practice.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据